ROTAVAC®

BIOLOGICAL3 trials

Sponsors

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products, Centre for Infectious Disease Research in Zambia, Bharat Biotech International Limited

Conditions

DiarrheaDiarrhea RotavirusRotavirus GastroenteritisRotavirus Infections

Phase 2

Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia

CompletedNCT03602053

Centre for Infectious Disease Research in ZambiaDiarrhea, Diarrhea Rotavirus

Start: 2019-01-22End: 2019-10-04Updated: 2020-12-19

Phase 3

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological ProductsRotavirus Infections

Start: 2018-02-08End: 2019-05-31Target: 360Updated: 2019-03-25

To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus

CompletedNCT04819412

Bharat Biotech International LimitedRotavirus Gastroenteritis

Start: 2015-03-20End: 2016-12-30Updated: 2021-03-29